Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Why Teva Pharmaceutical Industries Stock Is On Fire Today
12:13pm, Wednesday, 27'th Jul 2022 The Motley Fool
The drugmaker's opioid litigation may soon be resolved.
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
12:13pm, Wednesday, 27'th Jul 2022
Yahoo Finance anchor Brad Smith reports the latest notable business headlines including pharmaceutical company Teva reaching an opioid settlement, Credit Suisse naming Ulrich Koerner as the company's
Alphabet, Microsoft And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:29am, Wednesday, 27'th Jul 2022 Benzinga
Pzena Investment Management, Inc (NYSE: PZN) rose 46.4% to $9.43 in pre-market trading as the company said it has entered into an agreement to become a private company. The company also reported a ri
Teva Pharmaceutical Soars After Inking More Than $4 Billion In Opioid Deals
11:29am, Wednesday, 27'th Jul 2022
Teva Pharma inked settlement deals worth upward of $4 billion for its role in the opioid crisis, and Teva stock skyrocketed on Wednesday. The post Teva Pharmaceutical Soars After Inking More Than $4 B
TEVA Stock Surges 24% as Teva Pharmaceuticals Settles Lawsuits
11:03am, Wednesday, 27'th Jul 2022
Source: JHVEPhoto / Shutterstock.com Teva Pharmaceuticals (NYSE: TEVA ) stock is soaring higher on Wednesday after the pharmaceutical company reached a settlement in recent lawsuits. According to rece
Pharma Stock Explodes After Massive Settlement, Earnings
10:55am, Wednesday, 27'th Jul 2022
Shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are exploding today, after the drugmaker agreed to pay up to $4.25 billion for its alleged role in the U.S. opioid crisis.
Wall Street Breakfast: Ladies And Gentlemen ... The Fed
10:44am, Wednesday, 27'th Jul 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
10:34am, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.
Pzena Investment Mana
Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia
09:14am, Wednesday, 27'th Jul 2022
Teva Pharmaceutical will pay $75 million over 15 years and provide free opioid overdose treatment for 10 years. Teva stock rocketed.
Teva's stock jumps 25% after announcing $4.2 billion deal to resolve opioid lawsuits
08:22am, Wednesday, 27'th Jul 2022
Shares of Teva Pharmaceutical Industries Ltd. TEVA, -0.97% soared 25.7% in premarket trading on Wednesday, the day after the company said it will pay $4.25 billion to states, plus an additional $100 m
Why Teva Pharmaceutical Industries Stock Is On Fire Today
08:13am, Wednesday, 27'th Jul 2022
The drugmaker's opioid litigation may soon be resolved.
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits
10:06pm, Tuesday, 26'th Jul 2022
Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the US opioid epidemic.
Teva Pharma shares jump 17% on pending agreement over opioid litigation
09:54pm, Tuesday, 26'th Jul 2022 MarketWatch
Teva ADRs jump 17% to $8.31 late Tuesday after the company reaches agreement in principle to resolve the majority of its opioid-related litigation.
Why Teva Pharmaceuticals Stock Is Soaring After Hours
09:40pm, Tuesday, 26'th Jul 2022 Benzinga
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.
Teva said second-quarter revenue decr
Teva reaches proposed $4.25 billion settlement of U.S. opioid lawsuits
05:11pm, Tuesday, 26'th Jul 2022
Teva Pharmaceutical Industries announced a $4.25 billion proposed nationwide settlement on Tuesday that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemi
